<!DOCTYPE html>
<html lang="en"><!-- InstanceBegin template="/Templates/page_layout.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<meta charset="utf-8" />

<!-- InstanceBeginEditable name="doctitle" -->

<title>VCU Office of Research and Innovation - IRB Written Policies and Procedures</title>

<!-- InstanceEndEditable -->

<meta name="viewport" content="width=device-width, initial-scale=1.0" /><!--iPhone image scaling fix-->

<link href="../../css/page_layout.css" rel="stylesheet" type="text/css" media="all"/>
<link href="../../css/media_queries.css" rel="stylesheet" type="text/css" media="all"/>
<link rel="stylesheet" href="../../css/print.css" type="text/css" media="print" />
<link href='http://fonts.googleapis.com/css?family=Enriqueta:400,700' rel='stylesheet' type='text/css'>

<link REL="SHORTCUT ICON" HREF="http://www.research.vcu.edu/favicon.ico"> <!--icon in the address bar...do NOT delete-->
   
<script type="text/javascript" src="http://www.research.vcu.edu/js/respond.js"></script>

<!--[if IE 6]>
	<link a href="http://www.research.vcu.edu/css/IE_fixes/IE6.css" rel="stylesheet" type="text/css" media="all"/>
	<script type="text/javascript" src="http://www.research.vcu.edu/js/iehoverfix.js"></script>
<![endif]-->

<!--[if IE 7]>
	<link a href="http://www.research.vcu.edu/css/IE_fixes/IE7.css" rel="stylesheet" type="text/css" media="all"/>
	<script type="text/javascript" src="http://www.research.vcu.edu/js/iehoverfix.js"></script>
<![endif]-->

<!-- InstanceBeginEditable name="head" -->

<style>

	#top_nav #nav_human a {
		color:#fff;
		border-left:3px solid #fff;
		border-right:3px solid #fff;
	}

</style>

<!-- InstanceEndEditable -->

</head>

<body>

<div id="page">
	<div id="header">
    	<div id="logo_bar">
        	<a href="http://www.vcu.edu" target="_blank"><img src="../../images/identity_header/branding_bar.png" alt="VCU bar logo" id="vcu_logo_desktop" /></a>
            <a href="http://www.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/vcuseal.gif" alt="VCU logo" id="vcu_logo_mobile" /></a>
       	</div>
        <span id="skip_link"><a href="#mainContent">skip to main content</a></span>
        <div id="identity_search">
        	<div id="vcu_research">
            	<a href="../../index.htm"><img src="../../images/identity_header/office_research.png" alt="Office of Research and Innovation" id="office_research" /></a>
        	</div><!--end vcu_research-->
			<div id="search">
  				<form action="http://search.vcu.edu/search" method="get">
  				<input type="text" name="q" id="searchField" placeholder="Search" />
                <input type="hidden" name="query" value="">
              	<input type="hidden" name="proxystylesheet" value="research">
          		<input type="hidden" name="output" value="xml_no_dtd">
               	<input type="hidden" name="client" value="research"> 
              	<input type="hidden" name="sort" value="date:D:L:d1">
               	<input type="hidden" name="entqr" value="3">
              	<input type="hidden" name="oe" value="UTF-8">
               	<input type="hidden" name="ie" value="UTF-8">
               	<input type="hidden" name="ud" value="1">
                <input type="hidden" name="site" value="research-main">
  				<label for="searchField">Search for:</label>
  				<button class="search_btn" type="submit"></button>
</form>
           	</div>
  		</div><!--end identity_search-->
  
<div id="top_nav_container">
<div id="top_nav">
	<ul>
		<li id="nav_prop_awards"><a href="../../osp/index.htm">Proposals &amp; Awards</a></li>
		<li id="nav_human"><a href="../index.htm">Human Research</a></li>
        <li id="nav_animal"><a href="https://www.vcu.edu/research/acup/index.htm">Animal Research</a></li>
        <li id="nav_tech"><a href="../../ott/index.htm">Innovation</a></li>
        <li id="nav_conduct"><a href="../../research_conduct/index.htm">Researcher Conduct</a></li>
	</ul>
</div>
</div> <!-- end top_nav_container -->
</div><!--end header-->
<div id="main">
	<div id="page_head">            
            <div id="heading_bar">
				<!-- InstanceBeginEditable name="heading bar" -->            	
                <h1>Human Research</h1>
				<!-- InstanceEndEditable -->     	
            </div><!--end heading_bar-->
            
            <div id="head_image">
		    <!-- InstanceBeginEditable name="head image" -->            	
                <img src="../../images/head_images/irb_wpp.jpg" alt="papers on a desk with people working" />
                <!-- InstanceEndEditable -->            
          	</div><!--end head image-->
    	</div><!--end page_head-->
	<div id="content">       
      <div id="content_text">
      <a id="mainContent"></a>
<!-- InstanceBeginEditable name="content" -->

<p id="breadcrumbs"><a href="../index.htm">Human Research</a> &raquo; <a href="../wpp_guide.htm">IRB Written Policies and Procedures</a></p>

<table id="irb_wpp_info" border="1">

<tbody>

<tr>

<td id="section" colspan="2"><p><strong>Section XVI:</strong></p>

<p><em><strong>FDA - Regulated Products</strong></em></p></td>

<td id="wpp"><p><strong>WPP #</strong>: XVI-5</p></td>

</tr>

<tr>

<td id="title" colspan="3"><p><strong>Title 5:</strong></p>

<p><strong><em>Non-Research (Treatment Use, Single Patient Use,   Parallel Track Program)</em></strong></p></td>

</tr>

<tr>

<td id="date"><p><strong>Effective Date:</strong></p>

<p>6-21-06</p></td>

<td id="history" colspan="2"><p><strong>Revision History:</strong></p>

<p>06-07-04</p></td>

</tr>

</tbody>

</table>

<p class="style4">Objective</p>

<p>To describe the non-research uses of investigational products where IRB   oversight is required, including emergency use, treatment use, single patient treatment use, and parallel track programs.</p>

<p class="style4">Description</p>

<p>IRB reviews the non-research use of investigational  drugs/devices the use of investigational drugs/devices if the physician  provides evidence that a treatment IND/IDE has been obtained or plans for a  single patient use (as described below in Section B). In all cases, treatment use of an investigational drug/device requires prospective IRB  approval as well as subject informed consent.</p>

<ol type="A">

  <li><em><strong>Emergency Use:</strong></em>

  <p>See the following VCU IRB WPPs regarding Non-Research Emergency Use:<br />

    <a href="XVI-3.htm" target="_blank">VCU IRB WPP#: XVI-3 (Emergency Use of Unapproved Medical Devices) </a><br />

    VCU IRB WPP#: XVI-4 (Emergency Use of Investigational Drugs or Biologics)</p>
    
    </li>

  <li><em><strong>Single Patient Use</strong></em>

  <ol type="1">

    <li>Definition: In non-emergency situations, single patient use allows a physician to obtain access to an investigational drug, device, or biologic upon receiving approval from the IRB. This approval is granted for the treatment of a single patient.</li>

    <li><p>Procedure: When an investigator desires to obtain single  patient use approval, the investigator submits an application and the  &quot;activity under review&quot; is assigned a VCU IRB identification number and sent through the new application procedure. The treatment use may occur only after IRB approval is obtained. Subsequent treatment use requires  FDA approval for a treatment IND/IDE [21 CFR 312.35].</p>    

    <p>The following must  be submitted to the IRB for Single Patient Use:</p>

    <ol type="a">

      <li>VCU IRB Application with all required attachments</li>

      <li>Title of the protocol must clearly indicate SINGLE PATIENT USE request</li>

      <li>Complete description of the use (non-research protocol)</li>

      <li>Drug/Biologic/Device brochures and labeling</li>

      <li>Reference to any applicable IND/IDE</li>

      <li>Previous safety data</li>

    </ol>
    
    </li>
    
    </ol>
    
    </li>

    <li><em><strong>Treatment Use:</strong></em>

      <ol type="1">

        <li>Definition: A treatment IND  is a treatment protocol that is added to an existing investigational new drug  application (IND), which allows physicians to treat qualifying patients according to the protocol,  and which provides additional data on the drug's safety and effectiveness.  Treatment INDs are available for patients with life-threatening or other  serious diseases for which no satisfactory alternative drug or other therapy  exists [21 CFR 312.34].</li>

        <li>Procedure: The FDA permits Treatment INDs only for drugs  that show some promise of therapeutic benefit. Two standards exist:

<ol type="a" class="no_margin">

              <li>For serious diseases, applications for Treatment INDs must show sufficient evidence of safety and  effectiveness to support the use. Ordinarily, this standard means that a drug  may be made available for treatment use either during Phase 3 investigations or after all clinical trials have been completed.</li>

              <li>For immediately life-threatening diseases, the evidence, taken as a whole, must show (i.e., there must be sufficient data reasonably to conclude) that the drug may  be effective for its intended use in its intended patient population and would  not expose the patients to whom the drug is to be administered to an  unreasonable and significant additional risk of illness or injury. Under this  standard, investigational drugs for treating immediately life-threatening  diseases may be made available for treatment use earlier than Phase 3, but  ordinarily not earlier than Phase 2 [21 CFR 312.34(a), 312.34(b)(2), and  312.34(b)(3)].</li>

</ol>

</li>

        <li><p>Treatment INDs must be reviewed by the VCU IRB prior to  their submission to the FDA and must comply with the regulations governing informed  consent (21 CFR Part 50) and IRBs (21 CFR Part 56) [21 CFR 312.34(c)]. While  the FDA will consider waiving local IRB review for Treatment INDs, if waiver is  in the best interests of the subjects and adequate alternative mechanisms for  human subject protection are provided (e.g., to avoid duplication when a  national review body has already reviewed the Treatment IND), VCU DOES REQUIRE  LOCAL IRB REVIEW.</p>

          <p>The following must be submitted to the IRB for  Treatment Use:</p>
          
      <ul>

        <li>VCU IRB Application with all required attachments</li>

        <li>Title of the protocol must clearly indicate TREATMENT  USE request</li>

        <li>Complete description of the use (non-research protocol)</li>

        <li>Drug/Biologic/Device brochures and labeling</li>

        <li>Reference to any applicable IND/IDE</li>

        <li>Previous safety data</li>

      </ul>
      
      </li>

      </ol>
      
      </li>

  <li><em><strong>Parallel Track Program:</strong></em>

  <ol type="1">

    <li><p><em>Definition: </em>The Parallel Track mechanism makes  available promising investigational agents as quickly as possible to persons  with AIDS and other HIV-related diseases while generating data on the safety  and effectiveness of the drug [Federal Register 57 (April 15, 1992):  13250-13259]. Under the FDA policy, persons with AIDS and HIV-related diseases  who are not able to take standard therapy or for whom standard therapy is no  longer effective, and who are not able to participate in ongoing controlled clinical  trials would have access to promising investigational drugs. </p></li>

    <li><p><em>Procedure:</em> Applications for consideration of  experimental therapies for Parallel Track expanded availability must be  submitted to the FDA as amendments to existing INDs.</p>

      <p>Parallel Track protocols are accomplished under the  Treatment IND mechanism, which is described above, and should be thought of as  a subset of the Treatment IND. They are distinguished from Treatment INDs by  the amount of evidence of effectiveness required. Treatment INDs may be granted  after sufficient data have been collected to show that the drug &quot;may be  effective&quot; and does not have unreasonable risks, but before marketing  approval has been granted. According to the FDA, Parallel Track protocols  &quot;might be approved for promising investigational drugs when the evidence  for effectiveness is less than that generally required for a Treatment  IND&quot; [Federal Register 57 (April 15, 1992): 13256]. In other words,  Treatment INDs have represented an attempt to move drugs from late Phase 2 into  Phase 3, and Parallel Track represents an attempt to move drugs from late Phase  1 into Phase 2, both with the intended purpose of making promising new agents  available to persons with life-threatening diseases who cannot participate in controlled  clinical trials and for whom there are no satisfactory alternative therapies.  In addition, the Parallel Track mechanism is available only for AIDS and other  HIV-related diseases, while the Treatment IND is available for a number of  serious or life-threatening conditions.</p>

      <p>While both DHHS and the FDA may allow waiver of  local IRB review for certain Parallel Track programs, the VCU REQUIRES VCU IRB  REVIEW.
      
      </li>

 </ol>
 
 </li>
 
 </ol>

<p class="style4">Responsibility</p>

<p>It is the responsibility of the medical professional to determine the appropriate type of non-research treatment and meet all regulatory requirements prior to submission to the IRB.</p>

<p class="style4">References</p>

<p><a href="http://www.fda.gov/oc/ohrt/irbs/drugsbiologics.html" target="_blank">FDA Information Sheet: &quot;Treatment Use of Investigational  Drugs&quot;</a><br />

    <a href="http://www.fda.gov/oc/gcp/regulations.html" target="_blank">21 CFR 56.104</a></p>

<!-- InstanceEndEditable -->
      </div><!--end content_text-->
    </div><!--end content-->    
    <div id="right_nav">
    
    	<div class="nav_heading">VP for Research and Innovation &#187;</div>
        	<ul>
        		<li><a href="../../vpr/index.htm">VP for Research and Innovation</a></li>
                <li><a href="../../centers_cores/institutes.htm">Institutes and Centers</a></li>
                <li><a href="../../centers_cores/core_laboratories.htm">Research Cores</a></li>
                <li><a href="../../vpr/research_fund/index.htm">Research Quest Fund</a></li>
                <li><a href="../../vpr/grant_writing/index.htm">Grant Writing Institute</a></li>
                <li><a href="../../research_development/index.htm">Research Development</a></li>
                <li><a href="../../ugresources/index.htm">Undergraduate Research</a></li>
        		<li><a href="../../postdoc/index.htm">Postdoctoral Services</a></li>               
        	</ul>
            
    	<div class="nav_heading">Research Quick Links &#187;</div>
        	<ul>                               
                                
                <li><a href="../../vpr/research_compliance.htm">Research Compliance Matrix</a></li>
                <li><a href="../../vcuera/index.htm">VCUeRA</a></li>
                <li><a href="../../forms/index.htm">Forms</a></li>
                <li><a href="../../events/index.htm">Events</a></li>
                <li><a href="../../policies/index.htm">Policies</a></li>                
                <li><a href="../../vpr/contactus.htm">Contact a Specific Office</a></li>
                <li><a href="http://www.adobe.com/products/acrobat/readstep2.html" target="_blank">Download Adobe Reader</a><!-- #BeginLibraryItem "/Library/pdf_logo.lbi" --><img src="../../graphics/pdf_logo.gif" alt="pdf logo" style="margin-bottom:-.25em;" /><!-- #EndLibraryItem --></li>
        	</ul>
        
     	<div id="helpline">
       	  <a href="http://www.assurance.vcu.edu/reporting.html" target="_blank"><img src="../../images/helpline.jpg" alt="Helpline Image: To report any concern or for more information, (888)242-6022; www.vcuhelpline.com; www.ethicspoint.com" /></a>   	    
        </div>
       	</div><!--end right_nav-->    
    
   <div id="signature">
  		<ul>
    		<li><a href="http://www.vcu.edu" target="_blank">Virginia Commonwealth University</a> | <a href="http://www.research.vcu.edu/" target="_blank">Office of Research and Innovation</a></li>
            <li>800 East Leigh Street  PO Box 980568 Richmond, VA 23298</li>
            <li><a href="mailto:erahelp@vcu.edu?subject=Website%20Comments" target="_blank">Contact Us</a> | Updated: <!-- #BeginDate format:Am3 -->08/11/2014<!-- #EndDate --> | <a href="../../sitemap.htm">Site Map</a> | <a href="http://ts.vcu.edu/cgi-bin/posh.pl">View text-only version</a></li>
     	</ul>
</div><!--end #signature-->

</div><!--end main-->

<div id="vcu_footer">

	<a href="http://www.makeitreal.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/makeitrealFooter.gif" alt="Make It Real" /></a>
    
    <a href="http://www.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/vcubar-footer.gif" alt="Virginia Commonwealth University" /></a>
    
</div>
	
</div><!--end .page-->
</body>
<!-- InstanceEnd --></html>
